Subtype

Male Reproductive System Neoplasm

Non-malignant1,533 active trials27 approved drugs58 evidence items

NCIt: C3054

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (286)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 286 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Clinical and MRI characteristics of germline pathogenic variant carriers diagnosed with prostate cancer.
Rory L Cochran, Madhangi Parameswaran, Nabih Nakrour et al. · Eur Radiol · Sep 28, 2026 · PMID 42806037 · candidate dictionary pubmed
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.
Anmbreen Jamroze, Renyuan Zhang, Emily Dougherty et al. · J Immunother Cancer · Sep 28, 2026 · PMID 42805760 · candidate dictionary pubmed
Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes in Non-metastatic Prostate Cancer.
Samuel Lichtman-Mikol, Serageldin Kamel Attia, Yilun Sun et al. · Int J Radiat Oncol Biol Phys · Sep 28, 2026 · PMID 42805409 · candidate dictionary pubmed
Diagnostic performance of 29-MHz micro-ultrasound using cognitive fusion with multiparametric MRI for the detection of clinically significant prostate cancer: a single-center retrospective study.
Cedric Idri, Floriane Michel, Michel Soulie et al. · Fr J Urol · Sep 28, 2026 · PMID 42805393 · candidate dictionary pubmed
Integrated reverse network toxicology and experimental validation identify PTP4A3 as a key target of Benzo[a]pyrene in prostate cancer.
Shiwang Yuan, Jiang Shi, Lin Jiang et al. · Chem Biol Interact · Sep 28, 2026 · PMID 42805285 · candidate dictionary pubmed
Language as a powerful "Influencer" in Prostate Cancer.
Adam B Weiner, Jessica Rett, Scott E Eggener · J Urol · Sep 28, 2026 · PMID 42804927 · candidate

dictionary

pubmed

Real-World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database.

Hideyasu Tsumura, Dai Koguchi, Ken-Ichi Tabata et al. · Prostate · Sep 27, 2026 · PMID 42801735 · candidate dictionary pubmed

NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients With Grade Group 1 Prostate Cancer in the MRI Era.

Eric V Li, Tae-Hee Kim, Michael K Wang et al. · Prostate · Sep 27, 2026 · PMID 42801734 · candidate dictionary pubmed

Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance.

Jack Campbell, Michelle I Higgins, Zhuo Tony Su et al. · Prostate · Sep 27, 2026 · PMID 42801731 · candidate dictionary pubmed

Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation.

Linjie Li, Ruixi Feng, Bingyang Zha et al. · Prostate · Sep 27, 2026 · PMID 42801730 · candidate dictionary pubmed

Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

Michael A Cilento, Hui-Ming Lin, Nicole Yeung et al. · Prostate · Sep 27, 2026 · PMID 42801727 · candidate dictionary pubmed

A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.

Paul Maroni, Tad A Manalo, Hannah Baker et al. · Mol Carcinog · Sep 27, 2026 · PMID 42801665 · candidate dictionary pubmed

Degrading GPX4 via Biomimetic Nanoparticle-Mediated In Situ Synthesis of Deep-Learning-Designed Binder-Degron Chimeras for Prostate Cancer Therapy.

Si-Han Zhang, Ye An, Na Zeng et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801636 · candidate dictionary pubmed

Dual Compartmentalization of GSTA4 Suppresses Ferroptosis to Drive Antiandrogen Resistance in Prostate Cancer.

Yong Luo, Wei Zhuang, Zean Li et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801628 · candidate dictionary pubmed

Analysis of NAT2 coding variants, combined genotypes, and haplotypes in prostate cancer susceptibility: a case-control study in an Iraqi Arab population.

Murtadha A Tarish, Bassam K Kudhair · Mol Biol Rep · Sep 27, 2026 · PMID 42801388 · candidate dictionary pubmed

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI.

Karsten Guenzel, Maarten G Poirot, Almar van Loon et al. · Eur Radiol · Sep 26, 2026 · PMID 42800842 · candidate dictionary pubmed

High-dose-rate brachytherapy boost with external beam radiotherapy for localized prostate cancer: Long-term outcomes and toxicity in 607 predominantly high-risk patients.

Mahbuba Choudhury, Femi Adeoye, Saiji Nageshwaran et al. · Brachytherapy · Sep 26, 2026 · PMID 42800726 · candidate dictionary pubmed

Is early imaging a pitfall? Effect of [⁶⁸Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer.

Enes Mustafa Kaya, Burcu Esen Akkaş, Mehmetcan Uluçay et al. · Ann Nucl Med · Sep 26, 2026 · PMID 42799856 · candidate dictionary pubmed

Head-to-head comparison of MRI-based PI-RR scoring system and 68 Ga-PSMA-PET/CT: enhancing prostate cancer recurrence detection after radical prostatectomy.

Ludovica Laschena, Martina Pecoraro, Emanuele Messina et al. · Radiol Med · Sep 25, 2026 · PMID 42789166 · candidate dictionary pubmed

Association of time to upfront treatment initiation with outcomes in metastatic hormone-sensitive prostate cancer: a 4-month landmark analysis.

Eisuke Iwaori, Takafumi Yanagisawa, Shintaro Narita et al. · World J Urol · Sep 25, 2026 · PMID 42789110 · candidate dictionary pubmed

Acute toxicity and patient-reported quality of life during daily online adaptive radiotherapy versus conventional IGRT for localized prostate cancer: a prospective parallel cohort study.

Goda Kalinauskaite, Luise A Künzel, Kerstin Rubarth et al. · Strahlenther Onkol · Sep 25, 2026 · PMID 42789071 · candidate dictionary pubmed

Re: Agne Krilaviciute, Nikolaus Becker, Sigrid V. Carlsson, et al. Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-aged Men - Data from the PROBASE Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.06.016.

Ola Bratt, Anna Lantz, Rebecka Arnsrud Godtman · Eur Urol · Sep 25, 2026 · PMID 42786067 · candidate dictionary pubmed

Predicting prostate cancer mortality using UK Biobank data: a multimodal machine learning approach.

Shwas Churi, Bodhayan Prasad, Bhautesh Jani · Eur J Cancer Prev · Sep 25, 2026 · PMID 42784517 · candidate dictionary pubmed

Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer.

Francesco Pellegrino, Ugo Giovanni Falagario, Ahmad Abbadi et al. · Eur Urol Oncol · Sep 25, 2026 · PMID 42791144 · candidate dictionary pubmed

Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.

Iago Zang Pires, Alexandre Yamada Fujimura, Marília Oberto da Silva Gobbo et al. · Cancer Chemother Pharmacol · Sep 24, 2026 · PMID 42786231 · candidate dictionary pubmed